Mother-Child AI agent links pregnancy records to newborn risks
Nature Medicine describes MoChiAgent, an LLM assistant that forecasts maternal complications and infant disease risk from routine EHR visit data.
Trending Now
Robinhood Ventures Fund II brings retail capital to healthcare AI
The NYSE-listed BDC devotes about 6.7% of assets to early-stage healthcare AI, from cancer screening to clinic operations.
Consumer chatbots are building a medical system outside hospitals
Two Harvard-affiliated physicians warn consumer chatbots are quietly building a parallel medical…
Reasoning gaps hold back AI agents in scientific discovery
MIT Technology Review argues AI agents need reasoning, not just more data,…
Stanford Health AI Week Highlights AI’s Growing Role in Medical Education, Patient Empowerment, and Life Sciences
Stanford Medicine's weeklong Health AI event across eight symposia explored how AI is empowering patients, reshaping medical education, accelerating cancer…
AI Emerges as a Game-Changer in Humanitarian Healthcare Crisis Response
AI is being harnessed to transform humanitarian healthcare, improving disaster response, disease surveillance, mental health…
HKUST Pioneers Micro-Robotics and AI Tools to Reshape Global Healthcare
From ultra-miniature surgical robots to gamified respiratory monitors, HKUST is redefining medical technology with innovations…
High-Quality Data Is Key to Unlocking AI’s Full Potential in Clinical Trials
AI is streamlining clinical trials and cutting drug development costs, but success hinges on data…
Owkin’s AI scientist lands at Boehringer Ingelheim labs
Boehringer Ingelheim licenses Owkin's K Pro AI scientist and multimodal oncology and immunology data.
New AI Model Accurately Detects Liver Tumors From Small Datasets, Revolutionizing Cancer Imaging
A team from Science Tokyo has developed a lightweight AI model, MHP-Net, that outperforms leading…
OpenEvidence logs zero invented citations as new AI models debut
An npj Health Systems audit finds no fabricated references across nearly 5,000 OpenEvidence citations.
Tempus AI acquires Personalis for $1.5B in precision medicine play
Tempus AI adds Personalis' liquid biopsy and tumor sequencing capabilities in a $1.5 billion acquisition.
Health systems deploy AI agents while wrestling trust and token costs
Health systems moving from pilot AI agents to production face twin challenges: maintaining clinical trust…
AI-Discovered Drug for Fatal Lung Disease Enters Phase 2a, Setting Global Milestone
The progression of Rentosertib offers a real-world glimpse into how AI is reshaping the future…
AI doctor startup Doctronic buys Summer Health for pediatric expansion
Doctronic's acquisition of text-based pediatric provider Summer Health opens a new front in AI-driven primary…
AI Helps Rural Hospitals Embrace Value Based Care Amid Budget Cuts
Rural healthcare facilities can leverage AI and value based care models due to their strong…